A case of chronic relapsing ANCA-associated microscopic polyangiitis successfully treated with plasma exchange

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 3, 2004, Pages 223-226

  Akioka, Yuko ^a,b   Hattori, Motoshi ^a,c   Kawaguchi, Hiroshi ^a   Ito, Katsumi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

^c NONE   (Japan)

Author keywords

ANCA associated glomerulonephritis; Antineutrophil cytoplasmic autoantibody; Microscopic polyangiitis; Plasma exchange

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; STEROID;

ANTIBODY TITER; BONE MARROW SUPPRESSION; CARCINOMA; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; FEMALE; GLOMERULONEPHRITIS; GONADAL DISEASE; GROWTH RETARDATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LUNG HEMORRHAGE; MICROSCOPIC POLYANGIITIS; MORTALITY; OUTCOMES RESEARCH; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; PROTEINURIA; RECURRENT DISEASE; REMISSION; RENAL PROTECTION; SHORT STATURE; SMALL VESSEL VASCULITIS; URINARY TRACT INJURY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GLOMERULONEPHRITIS; HEMATURIA; HEMORRHAGE; HUMANS; LUNG; PLASMA EXCHANGE; PROTEINURIA; RECURRENCE; TREATMENT OUTCOME; VASCULITIS;

EID: 3142545664     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00150.x     Document Type: Conference Paper

References (10)

1. Falk RJ, Nachman PH, Hogan SL, Jennette JC. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol 2000;20:233-43.
2. Hattori M, Kurayama H, Koitabashi Y. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 2001;12:1493-500.
3. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated disease. A review of the clinical and laboratory features. Kidney Int 2000;57:846-62.
4. Levy J. New aspects in the management of ANCA-positive vasculitis. Nephrol Dial Transplant 2001;16:1314-7.
5. Savage COS. ANCA-associated renal vasculitis, Kidney Int 2001;60:1614-27.
6. Kamesh L, Harper L, Savage COS. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60.
7. Gaskin G, Pusey CD. Plasmapheresis in antineutrophil cytoplasmic antibodies-associated systemic vasculitis. Ther Apher 2001;5:176-81.
8. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis 1999;33:427-33.
9. Tesar V, Rihova Z, Jancova E, Rysava R, Merta M. Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials. Nephrol Dial Transplant 2003:18;v2-4.
10. Jayne D, Rasmussen N, Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies. N Eng J Med 2003;349:36-44.